眉间肌肉的解剖及眉间纹治疗进展(5)
[39]Moers-Carpi M，Fulford-Smith A，Tan K.A multicenter， randomized， double-blind study to evaluate the efficacy of onabotulinumtoxina (20 units) in the treatment of glabellar lines， when compared to incoboulinumtoxina (30 units)[J].J Am Acad Dermatol，2012，66(481)：AB20.
[40]Fulford-Smith A，Gallagher CJ，Brin MF. Multicentre， randomized，phase III study of a single dose of incobotulinumtoxinA， free from complexing proteins，in the treatment of glabellar frown lines[J].Dermatol Surg，2013，39(7)：1118-1119.
[41]Stephan S，Wang TD.Botulinum toxin： clinical techniques，applications，and complications[J].Facial Plast Surg，2011，27(6)：529-539.
[42]Jankovic J，Schwartz K.Response and immunoresistance to botulinumtoxin injections[J].Neurology，1995，45(9)：1743-1746.
[43]Dressler D.Clinical presentation and management of antibody-induced failure of botulinum toxin therapy[J].Movement Disorders，2004，19(S8)：S92-S100.
[44]Stengel，Gabriele，Eva Kristina Bee. Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines[J]. Clin Intervent Aging，2011，6：281-284.
[45]Lorenc ZP，Smith S，Nestor M，et al. Understanding the Functional Anatomy of the Frontalis and Glabellar Complex for Optimal Aesthetic Botulinum Toxin Type A Therapy[J].Aesthet Plast Surg，2013，37(5)： 975-983.
[收稿日期]2015-09-07 [修回日期]2015-11-11
编辑/李阳利, 百拇医药(樊雯君 杨柠泽)
[40]Fulford-Smith A，Gallagher CJ，Brin MF. Multicentre， randomized，phase III study of a single dose of incobotulinumtoxinA， free from complexing proteins，in the treatment of glabellar frown lines[J].Dermatol Surg，2013，39(7)：1118-1119.
[41]Stephan S，Wang TD.Botulinum toxin： clinical techniques，applications，and complications[J].Facial Plast Surg，2011，27(6)：529-539.
[42]Jankovic J，Schwartz K.Response and immunoresistance to botulinumtoxin injections[J].Neurology，1995，45(9)：1743-1746.
[43]Dressler D.Clinical presentation and management of antibody-induced failure of botulinum toxin therapy[J].Movement Disorders，2004，19(S8)：S92-S100.
[44]Stengel，Gabriele，Eva Kristina Bee. Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines[J]. Clin Intervent Aging，2011，6：281-284.
[45]Lorenc ZP，Smith S，Nestor M，et al. Understanding the Functional Anatomy of the Frontalis and Glabellar Complex for Optimal Aesthetic Botulinum Toxin Type A Therapy[J].Aesthet Plast Surg，2013，37(5)： 975-983.
[收稿日期]2015-09-07 [修回日期]2015-11-11
编辑/李阳利, 百拇医药(樊雯君 杨柠泽)